Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T65864 | Target Info | |||
Target Name | Stress-activated protein kinase 2a (p38 alpha) | ||||
Synonyms | SAPK2A; P38 mitogen activatedprotein kinase; P38 Mitogen-activatedprotein kinase alpha; Mitogen-activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; MXI2; MAX-interacting protein 2; MAPK 14; MAP kinase p38alpha; MAP kinase p38 alpha; MAP kinase MXI2; MAP kinase 14; Cytokine suppressive anti-inflammatory drug-binding protein; Cytokine suppressive anti-inflammatory drug binding protein; CSPB1; CSBP2; CSBP1; CSBP; CSAID-binding protein; CSAID binding protein; CRK1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | MAPK14 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Protein Name | Cyclic AMP-dependent transcription factor ATF-2 (ATF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRE.BP1; CREB.2; CREB2; HB16; TREB7 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Biochemical Activity | [1] | |||
2 | Biochemical Activity | [2] | |||
3 | Biochemical Activity | [3] | |||
4 | Biochemical Activity | [4] | |||
5 | Biochemical Activity | [5] | |||
6 | Biochemical Activity | [6] | |||
7 | Biochemical Activity | [7] | |||
8 | Biochemical Activity | [8] | |||
9 | Biochemical Activity | [9] | |||
10 | Biochemical Activity | [10] | |||
11 | Biochemical Activity | [11] | |||
12 | Biochemical Activity | [12] | |||
13 | Biochemical Activity | [13] | |||
14 | Biochemical Activity | [14] | |||
15 | Biochemical Activity | [15] | |||
16 | Biochemical Activity | [16] | |||
17 | Biochemical Activity | [17] | |||
18 | Biochemical Activity | [18] | |||
19 | Biochemical Activity | [19] | |||
20 | Biochemical Activity | [20] | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Biochemical Activity | [3] | |||
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Target Name | Sequestosome-1 p62 (SQSTM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-binding protein p62; Sequestosome-1; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62kDa; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa; OSIL; ORCA; EBIAP; EBI3-associated protein of 60 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [22] | |||
Ester hydrolases | [+] 4 Ester hydrolases | + | |||
Interacting Target Name | Dual specificity protein phosphatase 1 (DUSP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VH1; PTPN10; Protein-tyrosine phosphatase CL100; MKP-1; MKP1; Mitogen-activated protein kinase phosphatase 1; MAP kinase phosphatase-1; MAP kinase phosphatase 1; Dual specificity protein phosphatase hVH1; CL100 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [23] | |||
2 | Affinity Capture-Western | [24] | |||
3 | Affinity Capture-Western | [25] | |||
4 | Co-localization | [26] | |||
5 | Yeast two hybrid | [27] | |||
Interacting Protein Name | Dual specificity protein phosphatase 16 (DUSP16) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MKP.7; MKP7 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-Western | [24] | |||
4 | Reconstituted Complex | [24] | |||
5 | Yeast two hybrid | [27] | |||
Interacting Target Name | Dual specificity protein phosphatase 10 (DUSP10) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MKP-5; MKP5; Mitogen-activated protein kinase phosphatase 5; MAP kinase phosphatase 5 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [24] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Reconstituted Complex | [24] | |||
4 | Yeast two hybrid | [27] | |||
Interacting Protein Name | Dual specificity protein phosphatase 9 (DUSP9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MKP-4; MKP4; Mitogen-activated protein kinase phosphatase 4; MAP kinase phosphatase 4; Dual specificity protein phosphatase 9 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-MS | [31] | |||
4 | Reconstituted Complex | [1] | |||
Kinases | [+] 11 Kinases | + | |||
Interacting Target Name | MAPK-activated protein kinase 2 (MAPKAPK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MK-2; MK2; MAPKAP-K2; MAPKAPK-2; MAPKAP kinase 2; MAPKactivated protein kinase 2; MAP kinase-activated protein kinase 2; MAP kinaseactivated protein kinase 2 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [32] | |||
3 | Affinity Capture-MS | [29] | |||
4 | Affinity Capture-MS | [33] | |||
5 | Affinity Capture-MS | [31] | |||
6 | Affinity Capture-MS | [34] | |||
7 | Affinity Capture-Western | [35] | |||
8 | Biochemical Activity | [36] | |||
9 | Co-crystal Structure | [37] | |||
10 | Co-localization | [26] | |||
11 | Protein-Fragment Complementation Assay | [38] | |||
12 | Reconstituted Complex | [35] | |||
13 | Yeast two hybrid | [39] | |||
Interacting Target Name | MAPK-activated protein kinase 3 (MAPKAPK3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MAPKAPK3 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [32] | |||
3 | Affinity Capture-MS | [29] | |||
4 | Affinity Capture-MS | [33] | |||
5 | Affinity Capture-MS | [31] | |||
6 | Affinity Capture-MS | [34] | |||
7 | Biochemical Activity | [40] | |||
8 | Co-localization | [26] | |||
Interacting Protein Name | Ribosomal protein S6 kinase alpha-4 (RPS6KA4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MSK2; RSK.B | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [32] | |||
3 | Affinity Capture-MS | [29] | |||
4 | Affinity Capture-MS | [31] | |||
5 | Affinity Capture-Western | [41] | |||
6 | Biochemical Activity | [41] | |||
7 | Yeast two hybrid | [41] | |||
Interacting Target Name | MAPK signal-integrating kinase 1 (MKNK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mnk1; MAPK signal-integrating kinase 1; MAP kinase signal-integrating kinase 1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-MS | [31] | |||
4 | Affinity Capture-MS | [34] | |||
5 | Affinity Capture-Western | [30] | |||
6 | Yeast two hybrid | [27] | |||
Interacting Target Name | MAP kinase signal-integrating kinase 2 (MKNK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mnk2; MAPK signal-integrating kinase 2; MAP kinase signal-integrating kinase 2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-MS | [31] | |||
4 | Co-localization | [26] | |||
5 | Yeast two hybrid | [27] | |||
Interacting Protein Name | Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MAPKK3; MEK3; MKK3; PRKMK3; SAPKK.2; SAPKK2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-MS | [31] | |||
4 | Affinity Capture-Western | [42] | |||
5 | Fluorescence Resonance Energy Transfer | [43] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Biochemical Activity | [35] | |||
3 | Biochemical Activity | [44] | |||
4 | Fluorescence Resonance Energy Transfer | [43] | |||
Interacting Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Affinity Capture-Western | [46] | |||
4 | Protein-Fragment Complementation Assay | [38] | |||
Interacting Target Name | Ribosomal protein S6 kinase alpha-5 (RSK5) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | S6K-alpha-5; RSK-like protein kinase; RSKL; Nuclear mitogen- and stress-activated protein kinase 1; MSK1; 90 kDa ribosomal protein S6 kinase 5 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-Western | [30] | |||
4 | Yeast two hybrid | [27] | |||
Interacting Target Name | Stress-activated protein kinase 2b (p38 beta) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase-2; SAPK2b; SAPK2; PRKM11; P38b; P38-2; P38 Mitogen-activated protein kinase beta; Mitogen-activated protein kinase p38 beta; Mitogen-activated protein kinase 11; MAPK 11; MAP kinase p38 beta; MAP kinase 11 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [31] | |||
2 | Yeast two hybrid | [47] | |||
Interacting Target Name | Extracellular signal-regulated kinase 1 (ERK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM3; P44-MAPK; P44-ERK1; P44 Mitogen-activated protein kinase; Mitogen-activated protein kinase 3; Microtubule-associated protein-2 kinase; Microtubule-associated protein 2 kinase; MAPK 3; MAP kinase isoform p44; MAP kinase 3; Insulin-stimulated MAP2 kinase; ERT2; ERK-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Protein-Fragment Complementation Assay | [38] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [48] | |||
2 | Affinity Capture-Western | [49] | |||
3 | Affinity Capture-Western | [50] | |||
4 | Biochemical Activity | [50] | |||
5 | Biochemical Activity | [6] | |||
6 | Biochemical Activity | [49] | |||
7 | Protein-Fragment Complementation Assay | [38] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Protein Name | Myocyte-specific enhancer factor 2D (MEF2D) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Yeast two hybrid | [27] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Protein Name | ELM2 and SANT domain-containing protein 1 (ELMSAN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C14orf117; C14orf43; LSR68; c14_5541 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Yeast two hybrid | [27] | |||
Interacting Protein Name | TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 3.Tab1; MAP3K7IP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Affinity Capture-Western | [51] | |||
3 | Co-localization | [26] | |||
Interacting Protein Name | Transcription factor SPT20 homolog (SUPT20H) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C13; C13orf19; FAM48A; P38IP; SPT20 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Yeast two hybrid | [27] | |||
Interacting Protein Name | Hamartin (TSC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LAM; TSC | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Fluorescence Resonance Energy Transfer | [43] | |||
2 | Yeast two hybrid | [53] | |||
Interacting Protein Name | Zinc finger HIT domain-containing protein 1 (ZNHIT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CG1I; ZNFN4A1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [54] | |||
2 | Yeast two hybrid | [55] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 1998 May 22;280(5367):1262-5. | ||||
REF 2 | Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. Oncogene. 2008 Nov 6;27(52):6635-45. | ||||
REF 3 | Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol Cell Biol. 2011 Jun;31(11):2349-63. | ||||
REF 4 | Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2. J Biol Chem. 2001 May 11;276(19):16070-5. | ||||
REF 5 | Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J Biol Chem. 1997 May 30;272(22):14489-96. | ||||
REF 6 | DJ-1 modulates the p38 mitogen-activated protein kinase pathway through physical interaction with apoptosis signal-regulating kinase 1. J Cell Biochem. 2010 May;110(1):229-37. | ||||
REF 7 | CIIA negatively regulates neuronal cell death induced by oxygen-glucose deprivation and reoxygenation. Mol Cell Biochem. 2014 Dec;397(1-2):139-46. | ||||
REF 8 | The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem. 2000 Dec 15;275(50):38973-80. | ||||
REF 9 | Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995 Mar 31;270(13):7420-6. | ||||
REF 10 | P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. EMBO J. 2006 Feb 22;25(4):739-51. | ||||
REF 11 | p62 functions as a p38 MAP kinase regulator. Biochem Biophys Res Commun. 2000 Mar 16;269(2):521-5. | ||||
REF 12 | Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem. 2002 Apr 26;277(17):14408-16. | ||||
REF 13 | p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem. 1997 Aug 1;272(31):19509-17. | ||||
REF 14 | AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem. 2003 Jun 27;278(26):23432-40. | ||||
REF 15 | MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal. 2003 Nov;15(11):993-1001. | ||||
REF 16 | Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem. 2007 Feb 9;282(6):3766-77. | ||||
REF 17 | Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes. J Cell Biol. 2015 Sep 28;210(7):1117-31. | ||||
REF 18 | Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest. 2006 Oct;116(10):2727-38. | ||||
REF 19 | The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry. 1998 Sep 29;37(39):13846-53. | ||||
REF 20 | Tighter C-helix-L16-helix interactions seem to make p38 less prone to activation by autophosphorylation than Hog1. Biosci Rep. 2016 Apr 27;36(2). pii: e00324. | ||||
REF 21 | MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol. 2007 Nov 15;179(10):7101-9. | ||||
REF 22 | Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1. J Biochem. 2008 Jun;143(6):765-72. | ||||
REF 23 | Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators. Cell Rep. 2016 Nov 22;17(9):2488-2501. | ||||
REF 24 | A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J Biol Chem. 2001 Jul 13;276(28):26629-39. | ||||
REF 25 | Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem. 2001 May 11;276(19):16491-500. | ||||
REF 26 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 27 | A human MAP kinase interactome. Nat Methods. 2010 Oct;7(10):801-5. | ||||
REF 28 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 29 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 30 | Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 2001 Feb 1;20(3):466-79. | ||||
REF 31 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 32 | Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy. Sci Signal. 2015 Apr 7;8(371):rs3. | ||||
REF 33 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 34 | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods. 2013 Apr;10(4):307-14. | ||||
REF 35 | p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem. 2001 Feb 2;276(5):3517-23. | ||||
REF 36 | Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation. Biochem Biophys Res Commun. 1999 Dec 9;266(1):284-9. | ||||
REF 37 | Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6353-8. | ||||
REF 38 | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. Biochem J. 2011 Sep 15;438(3):495-503. | ||||
REF 39 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 40 | MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood. 2004 Dec 15;104(13):4260-8. | ||||
REF 41 | RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J Biol Chem. 1998 Nov 6;273(45):29661-71. | ||||
REF 42 | Mxi2 promotes stimulus-independent ERK nuclear translocation. EMBO J. 2007 Feb 7;26(3):635-46. | ||||
REF 43 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 44 | Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation. Exp Hematol. 2006 Oct;34(10):1360-76. | ||||
REF 45 | p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol Cell Biol. 2003 May;23(9):3079-90. | ||||
REF 46 | PAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway. J Biol Chem. 2008 Sep 5;283(36):24949-61. | ||||
REF 47 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. | ||||
REF 48 | TGFbeta1-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner. Cell Cycle. 2006 Dec;5(23):2787-95. | ||||
REF 49 | Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999 Dec 1;18(23):6845-54. | ||||
REF 50 | Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med. 2005 Jan 17;201(2):279-89. | ||||
REF 51 | TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem. 2003 Jan 24;278(4):2286-93. | ||||
REF 52 | Coordinated regulation of autophagy by p38alpha MAPK through mAtg9 and p38IP. EMBO J. 2010 Jan 6;29(1):27-40. | ||||
REF 53 | Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor. Mol Cell Proteomics. 2010 Jul;9(7):1578-93. | ||||
REF 54 | A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 2007 Apr 18;26(8):2115-26. | ||||
REF 55 | Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways. J Proteome Res. 2008 Sep;7(9):3879-89. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.